These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 20001576
1. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Szajewska H, Horvath A. Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576 [Abstract] [Full Text] [Related]
2. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S. Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [Abstract] [Full Text] [Related]
3. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses. Spieldenner J, Belli D, Dupont C, Haschke F, Iskedjian M, Nevot Falcó S, Szajewska H, von Berg A. Ann Nutr Metab; 2011 Jun; 59 Suppl 1():44-52. PubMed ID: 22189255 [Abstract] [Full Text] [Related]
4. Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double-blind trial. Szajewska H, Mrukowicz JZ, Stoińska B, Prochowska A. Acta Paediatr; 2004 Sep; 93(9):1159-65. PubMed ID: 15384877 [Abstract] [Full Text] [Related]
5. Modified proteins in allergy prevention. von Berg A. Nestle Nutr Workshop Ser Pediatr Program; 2009 Sep; 64():239-47; discussion 247-57. PubMed ID: 19710526 [Abstract] [Full Text] [Related]
6. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children. Iskedjian M, Haschke F, Farah B, van Odijk J, Berbari J, Spieldenner J. J Med Econ; 2012 Sep; 15(2):394-408. PubMed ID: 22171936 [Abstract] [Full Text] [Related]
7. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia. Su J, Prescott S, Sinn J, Tang M, Smith P, Heine RG, Spieldenner J, Iskedjian M. J Med Econ; 2012 Sep; 15(6):1064-77. PubMed ID: 22630113 [Abstract] [Full Text] [Related]
9. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children. Iskedjian M, Belli D, Farah B, Navarro V, Detzel P. J Med Econ; 2012 Sep; 15(2):378-93. PubMed ID: 22171935 [Abstract] [Full Text] [Related]
18. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis. Chung CS, Yamini S, Trumbo PR. Pediatrics; 2012 Aug; 130(2):e408-14. PubMed ID: 22778306 [Abstract] [Full Text] [Related]
19. Hypoallergenic formulas--when, to whom and how long: after more than 15 years we know the right indication! Høst A, Halken S. Allergy; 2004 Aug; 59 Suppl 78():45-52. PubMed ID: 15245358 [Abstract] [Full Text] [Related]
20. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high-risk children: a randomized controlled trial. Lowe AJ, Hosking CS, Bennett CM, Allen KJ, Axelrad C, Carlin JB, Abramson MJ, Dharmage SC, Hill DJ. J Allergy Clin Immunol; 2011 Aug; 128(2):360-365.e4. PubMed ID: 21696814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]